SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-000003
Filing Date
2024-01-02
Accepted
2024-01-02 06:04:03
Documents
2
Period of Report
2024-01-02

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea190974-6k_regencell.htm 6-K 14039
2 OFFER LETTER TO JAMES WAI HONG CHUNG, DATED DECEMBER 28, 2023 ea190974ex10-1_regencell.htm EX-10.1 31873
  Complete submission text file 0001213900-24-000003.txt   47049
Mailing Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077
Business Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077 852 2155 0823
Regencell Bioscience Holdings Ltd (Filer) CIK: 0001829667 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: 6-K | Act: 34 | File No.: 001-40617 | Film No.: 24500044
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)